Health Condition 1: K00-K95- Diseases of the digestive system Health Condition 2: N00-N99- Diseases of the genitourinary system Health Condition 3: M00-M99- Diseases of the musculoskeletal system and connective tissue
Conditions
Interventions
Intervention1: Intrathecal Magnesium Sulphate (0.2ml) 100mg in 3ml of 0.5% hyperbaric bupivacaine (15mg): Comparison of onset and duration of sensory and motor blockade and duration of postoperative
Sponsors
Parul Institute of Medical Science and Research
Eligibility
Inclusion criteria
Inclusion criteria: Patients willing to sign informed consent for undergoing elective spinal anaesthesia Patients undergoing infraumbilical surgeries Patients belonging to American Society of Anesthesiologists physical status I and II
Exclusion criteria
Exclusion criteria: Patients who are contraindicated for spinal anaesthesia Patients with known allergy, sensitivity or any other form of reaction to study drug (0.5% hyperbaric Bupivacaine, dexmedetomidine or magnesium sulphate) Pregnant or lactating patients or patients presenting for emergency surgeries
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset and duration of sensory block Onset and duration of motor block Hemodynamic stability Intensity and duration of post operative pain relief between two groups Sedation scale ComplicationsTimepoint: Onset of sensory block- from intrathecal injection to loss of pinprick sensation at T8 dermatome level Duration of sensory block- from onset to sensory regression to T10 dermatome level Onset of motor block- from intrathecal injection to achieve grade 3 motor block Duration of motor block- from onset to time to recede to grade 0 motor block Hemodynamic stability- immediately after block and at 5 minutes intervals for first 20 minutes then every 20 minutes till first rescue analgesic given Duration of post operative analgesia- from end of surgery at every 3o minutes till first rescue analgesic given Sedation scale- every 30 minutes till Sedation score 2 will be achieved Complications - for 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Sudha Shah
Parul Institute of Medical Science and Research
Outcome results
None listed